Caissa Capital Management ltd. - Apr 17, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
Apr 17, 2023
Transactions value $
$73,874
Form type
4
Date filed
4/18/2023, 04:08 PM
Previous filing
Apr 11, 2023
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $44.4K +15K +1.18% $2.96* 1.28M Apr 17, 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $29.4K +10K +0.78% $2.94* 1.29M Apr 18, 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182K Apr 17, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $3.09, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.82 to $3.01, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.